INT215518

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.57
First Reported 2007
Last Reported 2008
Negated 0
Speculated 1
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.43
Pain Relevance 0.88

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (Trim33) intracellular (Trim33) DNA binding (Trim33)
ligase activity (Trim33)
Trim33 (Mus musculus)
Pain Link Frequency Relevance Heat
adenocard 204 98.86 Very High Very High Very High
Glutamate 36 97.40 Very High Very High Very High
Glutamate receptor 6 95.12 Very High Very High Very High
tetrodotoxin 5 82.96 Quite High
depression 6 76.64 Quite High
antagonist 16 70.64 Quite High
agonist 14 34.72 Quite Low
noradrenaline 1 22.52 Low Low
Action potential 5 8.32 Low Low
Spinal cord 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pressure And Volume Under Development 26 98.60 Very High Very High Very High
Depression 6 76.64 Quite High
Stress 9 69.32 Quite High
Ganglion Cysts 10 52.20 Quite High
Targeted Disruption 7 19.40 Low Low
Retina Disease 5 5.00 Very Low Very Low Very Low
Cv Unclassified Under Development 2 5.00 Very Low Very Low Very Low
Convulsion 2 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Epilepsy 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Critical for the evaluation of scheme 1, is to test whether adenosine arises from the extracellular breakdown of ATP by using inhibitors of the ectoATPases and ecto-5’-nucleotidase.
Spec (whether) Negative_regulation (inhibitors) of ecto associated with adenocard
1) Confidence 0.57 Published 2008 Journal Current Neuropharmacology Section Body Doc Link PMC2701281 Disease Relevance 0.08 Pain Relevance 0.44
This assumption is supported by the finding that the inhibitor of ectoapyrases, ARL-67156, prevented the swelling-inhibitory effect of glutamate (Fig. 1g).
Negative_regulation (inhibitor) of ecto associated with pressure and volume under development and glutamate
2) Confidence 0.41 Published 2007 Journal Purinergic Signal Section Body Doc Link PMC2072913 Disease Relevance 0.35 Pain Relevance 0.44

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox